|
|
Article: PDI Signs Agreement with PharmaNetics to Sell and Provide Clinical Support for New Theranostic Test.
- Article from:
- PR Newswire
- Article date:
- November 26, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PDI, Inc. , a commercial sales and marketing partner to the biopharmaceutical and medical devices and diagnostics industries, and PharmaNetics, Inc. a leader in theranostic management specializing in the delivery of therapeutics affecting coagulation, today announced that they have signed an agreement under which PDI will provide a sales team and post sales clinical support for PharmaNetics' new ENOX Test. The ENOX Test is the first rapid, point-of-care test to be cleared in the U.S. to detect the anticoagulant effects of enoxaparin sodium.
"The deployment of both a sales force and a team of clinical specialists illustrates PDI's ability to offer a broad spectrum ...